Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan's novel glaucoma drug nears clinical trials

Nov. 2, 2000

Update on Pharmacia's ocular medications

Oct. 24, 2000

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Oct. 23, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

New series from Senju particularly useful for ocular disorders

Oct. 4, 2000

New ocular hypotensive agents in the Alcon pipeline

Sep. 8, 2000

New agents for glaucoma reported by Santen

Sep. 4, 2000

Visudyne sNDA granted priority review status

Sep. 1, 2000

Inspire reports synthesis of more stable P2Y2 agonists

Aug. 30, 2000

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

Aug. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...